3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13
Prostatic Neoplasms
9
Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Cardiovascular Diseases
3
Cardiotoxicity
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Ovarian Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Kidney Neoplasms
2
Heart Failure
2
Endometrial Hyperplasia
2
Carcinoma, Renal Cell
2
Waldenstrom Macroglobulinemia
1
Venous Thrombosis
1
Urogenital Neoplasms
1
Smoking
1
Sarcoma
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Overall Survival
1
Ototoxicity
1
Interventions
Antineoplastic Agents
3
Nutrition Assessment
2
Echocardiography
2
Blood Specimen Collection
2
liposomal doxorubicin
1
Vitamin E
1
Vital Signs
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Positron-Emission Tomography
1
Methods
1
Mass Screening
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hematologic Tests
1
Exercise Test
1
Chemoradiotherapy
1
Case Management
1
Breathing Exercises
1
Atorvastatin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Heart Diseases
×
Atorvastatin
×
Clear all
NCT02674204
2019-05-15
STOP
Cedars-Sinai Medical Center
Phase 2
Terminated
2 enrolled
7 charts